Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R/R acute myeloid leukemia AML"'
Autor:
Bin-Ru Wang, Chao-Ling Wan, Song-Bai Liu, Qiao-Cheng Qiu, Tian-Mei Wu, Jun Wang, Yan-Yan Li, Shuai-Shuai Ge, Yan Qiu, Xiang-Dong Shen, Sheng-Li Xue, Zheng Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The management of patients with relapsed or refractory (R/R) acute myeloid leukaemia (AML) remains a challenge with few reliably effective treatments. Chidamide, a new selective HDAC inhibitor, has demonstrated some effectiveness in AML patients. Her
Externí odkaz:
https://doaj.org/article/666477bf1ffb45baa59227e8b10908f1
Publikováno v:
Cancer Management and Research, Vol Volume 11, Pp 8073-8080 (2019)
Daniel R Reed,1 Ramey Z Elsarrag,2 Amy L Morris,3 Michael K Keng11Division of Hematology/Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA; 2Department of Medicine, University of Virginia, Charlottesville, VA, USA; 3D
Externí odkaz:
https://doaj.org/article/0ac22375ab1d46d98324f5388e457b03
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Management and Research
Recently there has been a significant progression in the understanding of molecular mutations driving biochemical and cellular signaling changes leading to survival and proliferation of leukemia cells in patients with acute myeloid leukemia (AML). Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a9a1747c233fb30a8c2a7eee810476d2
https://pubmed.ncbi.nlm.nih.gov/31564968
https://pubmed.ncbi.nlm.nih.gov/31564968